In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys
May 19, 2023... The Tune Therapeutics results are the first published data showing successful CRISPR epigenome editing in non-human primates.
New research may give geneticists a long-sought tool: a targeted protein delivery device
March 29, 2023... New research from a CRISPR pioneer offers a potential solution to delivery challenges that have long stunted genetic medicine.
Mice with two fathers and base-edited baby monkeys highlight potential — and limitations — of hereditable gene editing
March 9, 2023... New research on mice points to the eventual possibility of male-male couples having children who are genetically related to both of them.
New weight loss drugs are changing the narrative on obesity, with a push from pharma
March 5, 2023... A new generation of obesity drugs is transforming patients’ lives, dividing medical experts, and spurring the biggest business battle in years. And pharma is steering the discussion.
Ahead of genome summit in London, questions linger about CRISPR baby scandal
March 3, 2023... The organizers of the genome summit are still grappling with the fallout of the 2018 CRISPR baby scandal and the ethical debate it ignited.
CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools
March 1, 2023... The next CRISPR gene-editing patent war might look quite different; it's shaping up to be a free-for-all among a multitude of companies and labs.
How medicine’s revolutionary advances are changing the way we live
Jan. 17, 2023... How precise can gene editing be? Will researchers succeed in extending the “healthspan” of people’s lives? Can telehealth provide responsible mental health care? Do firewalkers hold the key to easing pain? Some of the world’s top biotech researchers, public health experts, and industry executives took on these questions and more at our 2022 STAT Summit,…
Perfection is too high a bar for CRISPR treatments, says STAT Biomedical Innovation Award winner David Liu
Nov. 15, 2022... Broad Institute biochemist David Liu was named the recipient of STAT’s 2022 Biomedical Innovation Award at the #STATSummit for expanding the CRISPR gene-editing toolkit.
Brain implants that translate paralyzed patients’ thoughts into speech creep closer to reality
Nov. 8, 2022... In a new study, a brain implant was able to decode more than 1,100 words from the electrical activity inside a paralyzed patient's brain as he silently tried saying the letters.
After early wins, CRISPR gene editing is about to get a lot harder
Sept. 21, 2022... So far CRISPR has focused on tissues — liver and blood cells — easy for bioengineers to reach. Researchers will have to figure out ways to reach complex areas like muscle safely and efficiently.
Up and down the ladder: The latest comings and goings
July 22, 2022... From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
Verve Therapeutics begins human tests of first ‘base editor,’ aiming at heart disease
July 12, 2022... The first patient ever has been dosed with a kind of gene-editing treatment known as a base editor, a newer way of utilizing CRISPR for gene editing.
STAT announces fourth annual 2022 STAT Summit
July 5, 2022... 2022 STAT Summit to feature Pfizer Chairman & CEO, Albert Bourla, Merck Executive Chairman, Ken Frazier, and Eli Lilly Chair & CEO, Dave Ricks BOSTON, MA – Today, STAT, the nation’s must-read health, science, and medicine publication, is proud to announce the 2022 STAT Summit. The two-day, in-person event will take place on November 15-16,…
2022 STAT Summit
June 22, 2022... Nov 15 & 16Boston#STATSummit Get ticketsView Speakers The 2022 STAT Summit is now complete Thank you to the speakers and to all who tuned into our annual flagship Summit event. Be sure to catch up with coverage from the event, and learn more about all of our upcoming Summits. About From trials to triumph: healing…
Four neuroscientists win Kavli Prize for discovering genes behind serious brain disorders
June 1, 2022... Four neuroscientists who discovered the genes involved in a host of serious brain disorders won this year’s $1 million @KavliPrize in neuroscience.
Up and down the ladder: The latest comings and goings
May 13, 2022... From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
Up and down the ladder: The latest comings and goings
March 4, 2022... From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.
David Liu
Feb. 16, 2022... In July 2021 Liu raised $315 million to launch Prime Medicine, which aims to use prime editing, a DNA-rewriting method developed in his Broad Institute lab, to treat rare genetic diseases. It’s the sixth startup co-founded by Liu, who has invented multiple tools for precision genetic medicine. Another, Beam Therapeutics, advanced several research programs last…
Up and down the ladder: the latest comings and goings
Jan. 28, 2022... Here's your rundown of the latest hires, departures, and promotions the pharmaceutical industry.
Pharmalittle: Pfizer makes a major push into mRNA technology; Medicare decision on Alzheimer’s drug may hurt state budgets
Jan. 10, 2022... A preliminary decision on Medicare coverage for the Biogen Alzheimer's drug is due this week, and it has major implications for state Medicaid programs.
Pfizer to pay Beam $300 million in gene-editing deal, amping up its mRNA ambitions
Jan. 10, 2022... A new Pfizer deal with Beam Therapeutics is a loud announcement of the company's interest in base editing for mRNA drug and vaccine development.
Up and down the ladder: The latest comings and goings
Jan. 7, 2022... From new hires to departures, promotions, and transfers, here are the latest comings and goings in the pharmaceutical industry.
3 CRISPR editing innovations to watch in 2022
Jan. 5, 2022... Here are three emerging CRISPR frontiers that we think it’s worth keeping an eye on in 2022 and beyond.
How Brigham Health helped create a Chinese hospital for elites — and almost nobody came
Dec. 26, 2021... In a deal worth millions with Chinese developer Evergrande, a Harvard teaching hospital risked its reputation on what would become a near-empty shell.
Medicine’s first autonomous AI could prevent blindness due to diabetes — if it can reach those most in need
Dec. 16, 2021... “How do we use these new innovative technologies to really mitigate disparities in diabetes outcomes?” asked Risa Wolf, a pediatric endocrinologist at Johns Hopkins Hospital.
New CRISPR tools could fix diseases caused by large DNA rearrangements, scientists report
Oct. 14, 2021... The success in mice bolsters hopes that newer generations of genome editors will be able to correct extensive and complicated glitches currently out of reach.
Two scientists win Nobel Prize in medicine for how we sense temperature and touch
Oct. 4, 2021... Two California-based scientists have won the 2021 Nobel Prize in medicine or physiology on Monday for their discoveries of receptors for heat, cold, and touch.
On a day to celebrate the Nobel in medicine, a stain still mars the institute that awards it
Oct. 4, 2021... Medical research — and its oversight — is built on a foundation of trust. Blaming whistleblowers for complicity in the abuses they have reported will have a chilling effect on witnesses coming forward.
Up and down the ladder: The latest comings and goings
Sept. 24, 2021... From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry.